This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
Published Guidance
Share |

ISTH Guidance developed and published to date:

 

Volume 18 (2020)

Goldenberg, N.A., Sochet, A., Albisetti, M., Biss, T., Bonduel, M., Jaffray, J., MacLaren, G., Monagle, P., O’Brien, S., Raffini, L., Revel‐Vilk, S., Sirachainan, N., Williams, S., Zia, A., Male, C. and (2020), Consensus‐Based Clinical Recommendations and Research Priorities for Anticoagulant Thromboprophylaxis in Children Hospitalized for COVID‐19‐Related Illness. J Thromb Haemost. Accepted Author Manuscript.

Zheng, XLVesely, SKCataland, SR, et al. ISTH guidelines for treatment of thrombotic thrombocytopenic purpuraJ Thromb Haemost2020182496– 2502.

Zuily, SCohen, HIsenberg, D, et al. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisJ Thromb Haemost2020182126– 2137.

Spyropoulos, ACLevy, JHAgeno, W, et al; the Subcommittee on Perioperative and Critical Care Thrombosis and Haemostasis of the Scientific, Standardization Committee of the International Society on Thrombosis and HaemostasisScientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19J Thromb Haemost2020181859– 1865

Zheng, XLVesely, SKCataland, SR, et al. Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpuraJ Thromb Haemost.2020182503– 2512.

Spyropoulos, A.C., Levy, J.H., Ageno, W., Connors, J.M., Hunt, B.J., Iba, T., Levi, M., Samama, C.M., Thachil, J., Giannis, D., Douketis, J.D. and (2020), Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19. J Thromb Haemost. Author Accepted Manuscript. 


Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C. and Iba, T. (2020), ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. J Thromb Haemost, 18: 1023-1026. 


Othman, M. and Gresele, P. (2020), Guidance on the diagnosis and management of Platelet‐ type von Willebrand Disease: a communication from the platelet physiology subcommittee of the ISTH. J Thromb Haemost. Author Accepted Manuscript. 


Di Nisio, M., Valeriani, E., Riva, N., Schulman, S., Beyer‐Westendorf, J. and Ageno, W. (2020), Anticoagulant Therapy for Splanchnic Vein Thrombosis. J Thromb Haemost. Author Accepted Manuscript. 


Tripodi, A., Cohen, H. and Devreese, K.M. (2020), Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. Author Accepted Manuscript. 


Zwicker, JI, Wang, TF, DeAngelo, DJ, et al. The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. J Thromb Haemost. 2020; 18: 278– 284.


Cooper, PCPavlova, AMoore, GWHickey, KPMarlar, RARecommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTHJ Thromb Haemost202018271– 277. 

Volume 17 (2019)

  • Wang, T. , Zwicker, J. I., Ay, C. , Pabinger, I. , Falanga, A. , Antic, D. , Noble, S. , Khorana, A. A., Carrier, M. and Meyer, G. (2019), The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH. J Thromb Haemost, 17: 1772-1778. doi:10.1111/jth.14564

  • Spyropoulos, A. C., Brohi, K. , Caprini, J. , Samama, C. M., Siegal, D. , Tafur, A. , Verhamme, P. , Douketis, J. D. and (2019), Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk. J Thromb Haemost, 17: 1966-1972. doi:10.1111/jth.14598

  • Delluc, A. , Wang, T. , Yap, E. , Ay, C. , Schaefer, J. , Carrier, M. and Noble, S. (2019), Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH. J Thromb Haemost, 17: 1247-1252. doi:10.1111/jth.14478

Volume 16 (2018)

  • Thomas W, Samama CM, Greinacher A, Hunt BJ, for the Subcommittee on Perioperative and Critical Care. The utility of viscoelastic methods in the prevention and treatment of bleeding and hospitalassociated venous thromboembolism in perioperative care: guidance from the SSC of the ISTHJ Thromb Haemost 201816: 2336–40.
  • Samuelson Bannow, BTLee, AKhorana, AAZwicker, JINoble, SAy, CCarrier, MManagement of cancerassociated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTHJ Thromb Haemost 2018161246– 1249.
  •  Tullius BP, Athale Uvan Ommen CHChan AKCPalumbo JSBalagtas JMSfor the Subcommittee on Hemostasis and Malignancy and the Subcommittee on Pediatric/Neonatal Thrombosis and HemostasisThe identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTHJ Thromb Haemost 20181617580.
  •  Godier A, Greinacher AFaraoni DLevy JHSamama CMUse of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTHJ Thromb Haemost2018161704.
  •  Khorana AA, Noble S, Lee AYY, Soff G, Meyer G, O'Connell C, Carrier M. Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTHJ Thromb Haemost 2018; 16: 1891–4.
  •  Harrison P, for the Subcommittee on Platelet Physiology. The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH.J Thromb Haemost 2018; 16: 1895–900.

Volume 15 (2017)

  • Delluc, A, Antic, D, Lecumberri, R, Ay, C, Meyer, G and Carrier, M. Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost 2017; 15:2076-2079.

Volume 14 (2016)

  • Cohen, H, Arachchillage, D.R, Middeldorp, S, Beyer-Wesendorf, J, Abdul-Kadir, R. Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH. J Thromb Haemost 2016; 14: 1673-1676. 
  • Kearon, C, Ageno, W, Cannegieter, S.C, Cosmi, B, Geersing, G.-J, Kyrle, P.A. and for the Subcommittees on Control of Anticoagulation and Predictive and Diagnostic Variables in Thrombotic Disease. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost 2016; 14:1480-1483. 
  • Martin, K, Beyer-Westendorf J, Davidson, B. L, Huisman, M. V, Sandset, P. M, and Moll, S. Use of Direct Oral Anticoagulants in Obese Patients: Guidance from the SSC of the ISTH. J Thromb Haemost 2016; 14:1308-1313.
  • Levy, J. H, Ageno, W, Chan, N. C, Crowther, M, Verhamme, P, Weitz, J. I. and for the Subcommittee on Control of Anticoagulation. When and how to use antidotes for the reversal of direct oral anticoagulants: Guidance from the SSC of the ISTH. J Thromb Haemost 2016; 14: 623-627. 
  • Collins, P, Abdul-Kadir, R, Thachil, J and for the SSC Subcommittees on Women's Issues in Thrombosis and Hemostasis and Disseminated Intravascular Coagulation.  Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. J Thromb Haemost 2016; 14:205-210.

Volume 13 (2015)

  • Di Nisio M, Lee A. Y. Y, Carrier M, Liebman H. A, Khorana A. A, and for the Subcommittee on Hemostasis and Malignancy. Diagnosis and treatment of the incidental venous thrombosis in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost 2015; 13:880-883. 
  • Thachil J, Falanga A, Levi M, Liebman H, Di Nisio M. Management of cancer-associate disseminate intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost 2015; 13:671-675
  • Gresele P, and for the Subcommittee on Platelet Physiology. Diagnosis of inherited platelet function disorders: Guidance  from the SSC of the ISTH. J Thromb Haemost 2015; 13:314-322.
Volume 12 (2014)
  • Khorana, A. A, H.-M. Otten, J. I. Zwicker, G. C. Connolly, D. F. Bancel, I. Pabinger and for the Subcommittee on Haemostasis and Malignancy. Prevention of Venous Thromboembolism in Cancer Outpatients: Guidance from the SSC of the ISTH. J Throm Haemost 2014; 12:1928-1931. 
  • Di Nisio, M, M. Carrier, G. H. Lyman, A. A. Khorana and for the Subcommittee on Haemostasis and Malignancy. Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH. J Throm Haemost 2014; 12:1746-1749.
  • Zwicker, J. I, G. Connolly, M. Carrier, P. W. Kamphuisen and A. Y. Y. Lee. Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH. J Throm Haemost 2014; 12:796-800
  • Devreese K. M,  S. S. Pierangeli, B. de Laat, A. Tripodi, T. Atsumi, T. L. Ortel and for the Subcommittee on Lupus Anticoagulant/Phospholipid/Dependent Antibodies. Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH. J Throm Haemost 2014; 12:792-795.
Volume 11 (2013)
  • Carrier M, Khorana A, Zwicker J, Noble S, Lee A, Management of challenging cases of patient with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH. J Throm Haemost 2013; 11: 1760-5.
  • Ageno W, Squizzato A, Wells PS, Büller HR, Johnson G. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost 2013; 11: 1597–602.
Volume 10 (2012)
  • Baglin T, Bauer K, Douketis J, Buller H, Srivastava A. and Johnson G. (2012), Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 10: 698–702

 

ISTH Guidance Commentary (Commentary published in JTH)

 

ISTH Endorsed Guidelines are produced by other organizations that relate to our Society and the meet the high ISTH standards.

Should you or your organization be interested in the development of guidelines, we encourage you to contact us and explore a possible collaboration or endorsement early on.

Membership Management Software Powered by YourMembership  ::  Legal